Navigation Links
AAAS hosts June 20 conference on personalized medicine
Date:6/12/2008

Better knowledge of the body's genetic and molecular machinery is pointing toward new drugs and treatments that are custom-designed for each individual. But this emerging era of personalized medicine, in which doctors aim to prescribe the right medicine in the right amount for the right patient, also brings concerns about genetic privacy, adequacy of insurance coverage and industry marketing strategies.

The American Association for the Advancement of Science and the Food and Drug Law Institute are sponsoring a two-part national conference on personalized medicine on June 20 at the AAAS Headquarters in Washington, D.C. from 9:00 a.m. to 5:00 p.m.

A morning roundtable session will explore personalized medicine through a hypothetical case study about a new biomarker for breast cancer recurrence. The panelists include scientists, government officials and a patient advocate.

The afternoon session on "Implementing Personalized Medicine" will feature a keynote speech by Dr. Mark B. McClellan, director of the Engelberg Center for Health Care Reform at the Brookings Institution and former head of the Food and Drug Administration. The participants include industry and FDA officials who must grapple with new regulatory and policy issues arising from advances in personalized medicine.

The morning roundtable will be moderated by Susan Dentzer, editor in chief of the journal Health Affairs.

The panelists are:

  • Finley Austin, head, U.S. External Research & Innovation Environment, Hoffmann-La Roche, Inc.
  • Carol Isaacson Barash, principal, Genetics, Ethics & Policy Consulting, Inc.
  • Greg Downing, program director for personalized health care, Office of the Secretary, Department of Health and Human Services
  • Carolina Hinestrosa, executive vice president of programs and planning, National Breast Cancer Coalition
  • Dr. Howard P. Levy, assistant professor, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University
  • Dr. Kavita Patel, deputy staff director, Senate Health, Education, Labor and Pensions Committee
  • Charles Rotimi, director, National Institutes of Health Intramural Center for Genomics and Health Disparities
  • Grail Sipes, partner, Covington & Burling

The afternoon session will be moderated by Jeffrey N. Gibbs, principal, Hyman, Phelps & McNamara, P.C. and Gail H. Javitt, law & policy director for The Genetics and Public Policy Center, The Johns Hopkins University.

The speakers are:

  • Kevin T. Conroy, president and chief executive officer, Third Wave Technologies, Inc.
  • Maryellen de Mars, director for clinical biomarkers, Critical Path Institute
  • Steven I. Gutman, director, Office of In Vitro Diagnostic Device Evaluation & Safety, FDA Center for Devices and Radiological Health
  • Shiew-Mei Huang, deputy director for science, Office of Clinical Pharmacology, FDA Center for Drug Evaluation and Research
  • David J. Hunter, professor of epidemiology and nutrition, Harvard School of Public Health
  • Steve McPhail, president and chief executive officer, Expression Analysis, Inc.
  • Bruce Quinn, senior health policy specialist, Foley Hoag LLP
  • Dr. Allen D. Roses, director, Deane Drug Discovery Institute, Duke University Medical Center; and senior scholar at the Fuqua School of Business

In addition to AAAS and FDLI, the following groups are participating in the conference:

American Society of Human Genetics
Association for Molecular Pathology
Genetic Alliance
The Hastings Center
International Pharmaceutical Privacy Consortium
The Kennedy Institute of Ethics at Georgetown University
Personalized Medicine Coalition


'/>"/>

Contact: Earl Lane
elane@aaas.org
202-326-6431
American Association for the Advancement of Science
Source:Eurekalert

Related medicine news :

1. Voices Against Brain Cancer Hosts Event to Benefit Brain Cancer Research
2. Cystic Fibrosis Foundation Hosts Quality Improvement Summit - Caregivers from 15 States and Canada Gather in Hartford for Intensive Learning
3. Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
4. SNM hosts 55th Annual Meeting of Nuclear Medicine and Molecular Imaging Research
5. TriWest Hosts Military Heroes at National Memorial Day Parade
6. American Red Cross Hosts Heritage of Service Dinner
7. ABQAURP Hosts Third Annual Medical Management Conference in Orlando
8. KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile
9. GACLA, Department of Health Hosts PA Latino Health Care Forum
10. Mission Community Hospital Hosts Spring Fundraiser to Refurbish Treasured Valley Emergency Room
11. Denzel Washingtons hometown hosts awarding of scholarships bearing Washington family name
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: